Drug trial hopes to control deadly spread of eye cancer
NCT ID NCT00421317
Summary
This study tested whether the drug imatinib could help control metastatic ocular melanoma, a serious cancer that starts in the eye and spreads. It involved 13 adult patients whose cancer had spread to other parts of their body. The main goal was to see if the treatment could stop the cancer from getting worse for at least three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Francois Baclesse
Caen, 14076, France
-
Centre Georges-Francois Leclerc
Dijon, 21079, France
-
Centre Gustave Roussy
Villejuif, 94805, France
-
Centre Hospitalier Regional Universitaire
Lille, 59035, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Leon Berard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre Paul Strauss
Strasbourg, 67065, France
-
Centre Val d'Aurelle Paul Lamarque
Montpellier, 34298, France
-
Hopital Universitaire de Hautepierre
Strasbourg, 67098, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut Curie
Paris, 75248, France
Conditions
Explore the condition pages connected to this study.